Advertisement
Screener

ImmuCell Corporation (ICCC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Cash Flow Breakdown

Cash flow breakdown shows where ImmuCell Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $2.48M came in.
  • Fiscal year ended 2025-12-31: from investing, $1.21M went out.
  • Fiscal year ended 2025-12-31: from financing, $1.21M went out.
  • Fiscal year ended 2025-12-31: change in cash, $48.60K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldNot split outChange in cash
2025-12-31$2.48M-$1.21M-$2.28M$349.33K$718.76K*$48.60K
2024-12-31$357.90K-$461.23K-$1.47M$0.00$4.65M$2.78M
2023-12-31-$4.67M-$1.89M-$1.19M$3.00M$0.00*$18.76K-$4.81M
2022-12-31-$1.54M-$3.96M-$897.13K$2.00M$30.67K-$4.39M
2021-12-31$954.17K-$1.60M-$768.27K$400.00K$165.34K$4.08M*$3.24M
2020-12-31$1.32M-$2.57M-$9.57M$11.54M$39.37K$656.64K
2019-12-31$233.51K-$3.40M-$861.35K-$500.00K$3.00$8.30M*$3.77M
2018-12-31-$373.40K-$1.79M-$398.31K$693.64K$500.00K$96.25K-$1.28M
2017-12-31$1.18M-$12.27M-$151.98K$6.15M$49.56K$3.70M*-$1.35M
2016-12-31-$222.31K-$4.52M-$135.84K$31.98K$8.43M*$3.58M
2015-12-31$2.90M-$4.62M-$169.75K$2.50M$120.21K$723.30K
2014-12-31$302.36K-$1.54M-$190.31K$0.00$3.15K-$1.42M
2013-12-31$1.10M-$1.34M-$181.44K$0.00$21.75K-$403.33K
2012-12-31$344.39K$1.66M-$172.85K$0.00$50.80K$1.89M
2011-12-31-$37.31K-$1.19M-$145.23K$600.00K$145.29K-$617.47K
2010-12-31-$808.61K$266.45K-$13.86K$1.00M$6.00K$423.50K
2009-12-31-$109.67K-$215.44K$0.00$0.00$99.75K-$224.44K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$3.02M*-$733.94K*-$402.54K*$0.00*
2026-03-31$3.57M-$167.23K-$400.00K$0.00$3.01M
2025-12-31$482.54K*-$167.31K*-$394.60K*$0.00*
2025-09-30-$1.18M*-$592.02K*-$1.12M*$2.33M$0.00*-$1.54M*
2025-06-30$1.60M*-$125.93K*-$381.44K*$329.89K*
2025-03-31$1.57M-$329.05K-$380.11K$19.43K$841.14K
2024-12-31-$3.05K*-$196.22K*-$374.23K*$0.00*$539.29K*
2024-09-30-$639.33K*-$88.41K*-$368.25K*$0.00$3.69M*
2024-06-30$581.78K*-$106.24K*-$364.35K*
2024-03-31$418.50K-$70.36K-$361.51K-$18.39K
2023-12-31-$723.07K*$33.78K*-$356.76K*$0.00*$0.00*
2023-09-30-$507.75K*-$533.26K*-$325.74K$3.00M$1.00M*-$2.10M*
2023-06-30-$681.43K*-$708.41K*-$251.90K$0.00*
2023-03-31-$2.76M-$682.15K-$251.38K$1.00M-$2.70M
2022-12-31-$1.30M*-$1.49M*-$248.21K*$0.00*-$2.00*
2022-09-30-$1.26M*-$734.31K*-$223.10K$0.00*$0.00*
2022-06-30$373.46K*-$943.29K*-$228.43K$0.00*$24.83K*
2022-03-31$638.53K-$796.50K-$197.38K$2.00M$5.84K$1.63M
2021-12-31$587.89K*-$703.28K*-$194.91K*$0.00*$0.00*
2021-09-30$258.99K*-$671.42K*-$192.36K*$153.64K*$78.43K
2021-06-30$730.83K*-$879.34K*-$190.63K*$13.00*$102.44K$4.13M*
2021-03-31-$623.55K$656.68K-$190.38K$11.68K-$143.29K
2020-12-31$156.25K*$756.32K*-$769.42K*$1.50M*-$32.63K*
2020-09-30-$667.33K*-$1.47M*-$143.17K$0.00*
2020-06-30$969.20K*-$2.57M*-$141.89K$1.44M
2020-03-31$857.45K$713.45K-$8.52M$8.60M$1.61M
2019-12-31-$46.62K*$4.20M*-$217.22K*$0.00*$1.00*$3.94M*
2019-09-30-$66.41K*$1.34M*-$215.17K$0.00*$0.00*$1.06M*
2019-06-30-$330.66K*-$8.74M*-$214.66K$0.00*$0.00*-$9.29M*
2019-03-31$677.20K-$203.32K-$214.30K-$500.00K$9.00M-$696.56K*$8.06M
2018-12-31-$138.35K*-$98.75K*-$214.42K*$0.00*$80.75K*$127.79K*
2018-09-30-$505.94K*$25.68K*-$72.14K$426.50K$4.64K*-$121.26K*
2018-06-30$21.22K*-$501.93K*-$71.95K$0.00*$6.70K*-$545.95K*
2018-03-31$249.66K-$1.22M-$39.80K$267.14K$4.16K-$738.34K
2017-12-31$330.71K*-$4.68M*-$39.99K*$3.12M*$33.06K*$2.73M*$1.49M*
2017-09-30-$255.12K*-$3.98M*-$38.41K*$2.18M$11.25K*-$1.54M*
2017-06-30-$155.12K*-$1.20M*-$38.28K$500.00K$0.00*-$404.39K*
2017-03-31$1.26M-$2.41M-$35.30K$340.00K$5.25K-$898.32K
2016-12-31-$270.46K*-$2.11M*-$35.30K*$0.00*$3.16M*$741.93K*
2016-09-30-$117.92K*$880.52K*-$33.72K*$28.82K*$757.72K*
2016-06-30$253.30K*-$1.12M*-$33.41K*$3.15K*-$910.61K*
2016-03-31-$87.24K-$2.17M-$33.41K$0.00$5.28M*$2.99M
2015-12-31$830.12K*-$1.69M*-$33.41K*$0.00*$0.00*-$895.76K*
2015-09-30$552.12K*-$2.52M*-$37.85K*$75.07K*$2.48M*$543.91K*
2015-06-30$116.24K*-$666.09K*-$49.43K*$39.89K*-$544.91K*
2015-03-31$1.40M$262.11K-$49.06K$5.25K$1.62M
2014-12-31$251.90K*-$519.42K*-$48.66K*$0.00*-$1.00*-$316.18K*
2014-09-30-$279.41K*-$207.49K*-$47.75K*$0.00*-$534.64K*
2014-06-30$25.03K*-$516.80K*-$47.11K*$0.00*-$538.88K*
2014-03-31$304.84K-$291.85K-$46.79K$3.15K-$30.65K
2013-12-31$83.83K*-$724.56K*-$46.40K*$21.75K*-$664.98K*
2013-09-30$79.37K*$461.27K*-$45.51K*$0.00*$495.13K*
2013-06-30$490.15K*-$325.46K*-$44.90K*$0.00*$119.79K*
2013-03-31$445.30K-$753.95K-$44.63K$0.00-$353.28K
2012-12-31$163.06K*$969.18K*-$44.24K*$0.00*$0.00*$1.09M*
2012-09-30-$137.49K*$732.38K*-$43.36K*$0.00*$0.00*$551.54K*
2012-06-30$126.96K*-$621.49K*-$42.77K*$0.00*$0.00*-$537.30K*
2012-03-31$191.85K$582.54K-$42.48K$0.00$50.80K$789.55K
2011-12-31$294.84K*-$52.80K*-$42.15K*$0.00*$17.13K*$217.97K*
2011-09-30-$357.94K*-$32.39K*-$41.34K*$0.00*$97.80K*-$327.70K*
2011-06-30-$208.96K*$215.82K*-$40.81K*$0.00*$30.37K*$3.82K*
2011-03-31$234.74K-$1.33M-$20.93K$600.00K$0.00-$511.56K
2010-12-31-$421.37K*-$1.00M*-$10.39K*$0.00*$6.00K*-$1.43M*
2010-09-30-$112.67K*$227.01K*-$3.46K*$1.00M$0.00*$1.08M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92